Pricing
  1. JP-listed companies
  3. Financials
  4. Net income margin (%)

【JP:7079】

Market cap
¥6.4B
P/E ratio
8.5x
WDB Coco provides outsourcing services to help pharmaceutical companies with drug safety monitoring, regulatory document preparation, and clinical research support.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndNet income margin (%) YoY (%)
Mar 31, 202517.1-8.19%
Mar 31, 202418.7+2.18%
Mar 31, 202318.3+1.97%
Mar 31, 202217.9+23.42%
Mar 31, 202114.5+8.23%
Mar 31, 202013.4+0.98%
Mar 31, 201913.3-1.71%
Mar 31, 201813.5-4.51%
Mar 31, 201714.2+1.82%
Mar 31, 201613.9

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)